Sponsor Pipeline

Jiangsu Topcel-KH Pharmaceutical Co., Ltd. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
5
Active Trials
3
Recruiting
1
Phase 3
1
Disease Areas
Active Trials by Phase
Phase 3
1
Phase 1/2
1
Phase 1
3
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT06925594 Phase 3 Study of Human TH-SC01 Cell Injection for Treating Perianal Fistulas in Patients… Crohn's Disease Recruiting
Phase 1/2
NCT07452822 Safety and Efficacy Study of Human Umbilical Cord Mesenchymal Stem Cells in Preventing… Arteriovenous Fistula Stenosis Not Yet Recruiting
Phase 1
NCT07368270 Safety and Efficacy Study of Anti-PD1 Armored CD19 CAR-T Cells in Adult Subjects With… Diffuse Large B Cell Lymphoma Recruiting
NCT07369492 Safety and Efficacy Study of BAFF-R CAR-T Cells in Adult Subjects With CD19-Negative… B-cell Lymphoma Recruiting
NCT06925607 Evaluate the Distribution and Dynamic Behavior of Nuclide Labeled TH-SC01 Cells in Vivo… Radiation Proctitis Not Yet Recruiting
Disease Areas
Get alerts when Jiangsu Topcel-KH Pharmaceutical Co., Ltd.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free